Author Correction: Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men.
Hannawi S, Saf Eldin L, Abuquta A, Alamadi A, Mahmoud SA, Hassan A, Xu S, Li J, Liu D, Baidoo AAH, Ibrahim D, Alhaj M, Chen Y, Zhou Q, Xie L.
Hannawi S, et al. Among authors: zhou q.
Nat Commun. 2024 Jan 8;15(1):369. doi: 10.1038/s41467-024-44729-x.
Nat Commun. 2024.
PMID: 38191554
Free PMC article.
No abstract available.